US Stock MarketDetailed Quotes

EVH Evolent Health

Watchlist
  • 9.580
  • -0.380-3.82%
Close Mar 21 16:00 ET
  • 9.836
  • +0.256+2.67%
Post 20:01 ET
1.12BMarket Cap-11.83P/E (TTM)

Evolent Health Key Stats

Evolent Health Q4 2024 Earnings Date

Currency:USDFeb 20, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
650.92M
646.54M
-4.37M
Miss Est.
+17.06%
+16.27%
-0.67%
EPS
-0.28
-0.27
+0.01
Beat Est.
+21.23%
+25.00%
+4.76%
Strong Buy

Mar 21, 2025

Evolent Health Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 14 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 503.602M--
--2025/Q1-- / 460.151M--
Feb 20, 20252024/Q4646.542M / 650.916M--
Nov 7, 20242024/Q3621.401M / 627.151M--
Aug 8, 20242024/Q2647.145M / 636.414M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 503.602M--
--2025/Q1-- / 460.151M--
Feb 20, 20252024/Q4646.542M / 650.916M--
Nov 7, 20242024/Q3621.401M / 627.151M--
Aug 8, 20242024/Q2647.145M / 636.414M--

Unlock Free Earnings Estimates

Evolent Health Earnings Reports

Read more

Market Insights
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Mar 21, 2025

Strong Buy

  • Buy

    93.33%
  • Hold

    6.67%
  • Sell

    0.00%

Price Target

No Data